A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Chen, WenYong, Ph.D. Bookmark and Share

Laboratory of WenYong Chen, Ph.D.

DNA methylation and histone modification affect mammalian gene regulations and functions. These epigenetic modifications play important roles in many normal biological processes, such as development, stem cell differentiation and aging, as well as in several mental retardation diseases and cancer. Cancer evolves with the genetic loss of function of tumor suppressor genes and overactivity of oncogenes. Meanwhile, cancer progression also involves profound epigenetic deregulation of tumor suppressor genes, and chromatin alterations that affect genomic stability and gene expression. We are interested in understanding the biology of cancer with a focus on epigenetic regulation of tumor suppressor genes and oncogenes in development, aging and tumorigenesis, and developing mouse models for studying cancer epigenetics and testing strategies for cancer prevention and therapy.
Using mouse genetics, we demonstrate the important roles of an epigenetically regulated gene, hypermethylated in cancer 1(HIC1), in tumor suppression. We show that a key role for loss of HIC1 function in tumorigenesis is to activate the mammalian stress-response gene SIRT1 (an NAD-dependent protein deacetylase) and thereby deacetylate and inactivate p53. SIRT1 is a homologue of yeast Sir2 protein, a histone deacetylase that is involved in epigenetic gene silencing, suppression of recombination and maintenance of chromatin functions. SIRT1 protects mammalian cells from apoptosis under stress and DNA damage. Since aging increases promoter hypermethylation and epigenetic silencing of HIC1, these studies suggest that the resultant upregulation of SIRT1 may be a double-edged sword that both promotes survival of aging cells and increases cancer risk in mammals.
SIRT1 over-expression is prevalent in human and mouse cancers; however, the precise roles of SIRT1 in tumorigenesis are not well defined. Other members of the SIRT1 gene family termed sirtuins may also regulate cell metabolism and aging, but their functions in cancer are not well understood. The current research themes in the lab include investigating the roles of SIRT1 in BCR-ABL transformation of primitive hematopoietic progenitor cells and chemoresistance of chronic myelogenous leukemia to tyrosine kinase inhibitors, and studying the functions of sirtuins and NAD metabolism in epithelial cells and carcinogenesis. Our goals are to discern how sirtuins are involved in regulating cellular longevity and tumorigenesis and to develop strategies for healthy aging and reduced cancer risk.
 
For more information on Dr. Chen, please click here.

Chen, WenYong, Ph.D.

Laboratory of WenYong Chen, Ph.D.

DNA methylation and histone modification affect mammalian gene regulations and functions. These epigenetic modifications play important roles in many normal biological processes, such as development, stem cell differentiation and aging, as well as in several mental retardation diseases and cancer. Cancer evolves with the genetic loss of function of tumor suppressor genes and overactivity of oncogenes. Meanwhile, cancer progression also involves profound epigenetic deregulation of tumor suppressor genes, and chromatin alterations that affect genomic stability and gene expression. We are interested in understanding the biology of cancer with a focus on epigenetic regulation of tumor suppressor genes and oncogenes in development, aging and tumorigenesis, and developing mouse models for studying cancer epigenetics and testing strategies for cancer prevention and therapy.
Using mouse genetics, we demonstrate the important roles of an epigenetically regulated gene, hypermethylated in cancer 1(HIC1), in tumor suppression. We show that a key role for loss of HIC1 function in tumorigenesis is to activate the mammalian stress-response gene SIRT1 (an NAD-dependent protein deacetylase) and thereby deacetylate and inactivate p53. SIRT1 is a homologue of yeast Sir2 protein, a histone deacetylase that is involved in epigenetic gene silencing, suppression of recombination and maintenance of chromatin functions. SIRT1 protects mammalian cells from apoptosis under stress and DNA damage. Since aging increases promoter hypermethylation and epigenetic silencing of HIC1, these studies suggest that the resultant upregulation of SIRT1 may be a double-edged sword that both promotes survival of aging cells and increases cancer risk in mammals.
SIRT1 over-expression is prevalent in human and mouse cancers; however, the precise roles of SIRT1 in tumorigenesis are not well defined. Other members of the SIRT1 gene family termed sirtuins may also regulate cell metabolism and aging, but their functions in cancer are not well understood. The current research themes in the lab include investigating the roles of SIRT1 in BCR-ABL transformation of primitive hematopoietic progenitor cells and chemoresistance of chronic myelogenous leukemia to tyrosine kinase inhibitors, and studying the functions of sirtuins and NAD metabolism in epithelial cells and carcinogenesis. Our goals are to discern how sirtuins are involved in regulating cellular longevity and tumorigenesis and to develop strategies for healthy aging and reduced cancer risk.
 
For more information on Dr. Chen, please click here.
Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 


NEWS & UPDATES
  • Patients with metastatic colorectal cancer often stop responding to the primary drugs used against the disease, leaving them with few options and little hope. Determined to increase those options, doctors and researchers at City of Hope are conducting two clinical trials that could lead to new treatments for pe...
  • Investigators working at City of Hope are making many significant inroads against many forms of cancer. To do that, they have to take a variety of approaches. Molecular oncology researchers focus on abnormal cancer-associated activity in a cell’s nucleus. One especially prominent factor in many breast and ovari...
  • In light of the new breast cancer screening guidelines, which call for women to have mammograms every other year from age 50 to 74, it’s more important than ever for women to understand their individual risk. On Monday, the U.S. Preventive Services Task force released new breast cancer screening guideline...
  • Cancer patients need, and deserve, more than medical care. They and their families need high-quality supportive care – that is, care that addresses their physical, emotional and spiritual well-being. Health care professionals increasingly understand this, but starting such programs from scratch isn’t easy...
  • Each year, City of Hope patients given another chance at life gather to pose for a picture like this one. Going on its 39th year, the celebration of patients free of blood cancers thanks to bone marrow or stem cell transplants has grown such that a photographer has to scale a cherry picker just to […]
  • Cancer patients who are participating in early-stage clinical trials need extra emotional and physical support due to their additional stress and often unique symptoms. Now an effort by researchers at City of Hope to create a model for such support has received a $6.8 million grant from the National Cancer Inst...
  • The need for improvements in treating malignant brain tumors has never been greater. Survival for many patients with these tumors are sometimes measured in just months. One reason that therapeutic options are limited is that traditional surgery is deemed too risky for many brain tumors, especially for those in ...
  • “Honestly, there’s nothing special about my story,” protested Daniel Samson, as he bounced Layla, his 3 1/2-year-old daughter, on his lap and put on a video for her to watch. “I just want to tell it for my own sake, and share it with other men who may be going through this chaos.” Samson spoke […]
  • As far back as he can remember, Jonathan Yamzon, M.D., wanted to be a doctor. “I knew it from the get-go,” he said, matter-of-factly. “I always envisioned it as the ideal; the supreme thing one could do with one’s life.” The youngest of six children, Yamzon was barely a toddler when his family moved to [&...
  • There’s never a “good” time for cancer to strike. With testicular cancer, the timing can seem particularly unfair. This disease targets young adults in the prime of life; otherwise healthy people unaccustomed to any serious illness, let alone cancer. And suddenly … “I can only imagine what they must...
  • Sure, a healthy lifestyle can lower a person’s risk, but the impact of specific actions is harder to tease out. Diet, exercise, tobacco use, nutritional supplements, alcohol consumption … How important are each of these factors, individually? Does strict adherence to (or rejection of) one get you a pass o...
  • Health care decisions are tough. They’re even tougher when you – or loved ones – have to make them without a plan or a conversation. National Healthcare Decisions Day, on April 16,  is a nationwide initiative to demystify the health care decision-making process and encourage families to start talking. Ult...
  • The statistics, direct from the American Cancer Society, are sobering: Cancer death rates among African-American men are 27 percent higher than for white men. The death rate for African-American women is 11 percent higher compared to white women. Hispanics have higher rates of cervical, liver and stomach cancer...
  • “Lucky” is not usually a term used to describe someone diagnosed with cancer.  But that’s how 34-year-old Alex Camargo’s doctor described him when he was diagnosed with thyroid cancer — the disease is one of the most treatable cancers at all stages. That doctor was ultimately proved righ...
  • Geoff Berman, 61, starts his day with the motto: “The sun is up. I’m vertical. It’s a good day.” Ever since he’s been in remission from lymphoma, Berman makes a special point of being grateful for each day, reminding himself that being alive is a gift. “I just enjoy living,” he said. “I give e...